Jagdishkumar Devjibhai Ajudiya has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promoter Jagdishkumar Devjibhai Ajudiya has filed the annual disclosure under SEBI Takeover Regulations for the year ended 31st March 2025. The promoter continues to hold 1,40,70,898 shares, representing 70.17% of Indo Us Bio-Tech Limited. Importantly, the promoter has declared that no encumbrance (pledge, lien or lock-in) was created on these shares, directly or indirectly, during the entire financial year. This is a routine annual compliance filing confirming clean shareholding with no pledged collateral.
Neutral to slightly positive for retail investors — confirms the promoter's 70.17% stake remains unencumbered, meaning no shares are pledged as collateral, reducing risk of forced selling or margin calls from promoter holdings.